Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Net income (loss)	$ 1,041,000,000	$ (82,000,000)	$ 4,700,000,000
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities
Gain on disposal of businesses and assets	(78,000,000)	0	0
Depreciation and amortization	1,093,000,000	1,123,000,000	1,011,000,000
Deferred and prepaid income taxes	(124,000,000)	(82,000,000)	(4,301,000,000)
Stock-based compensation expense	194,000,000	170,000,000	157,000,000
Goodwill and other intangible asset impairment charges	370,000,000	533,000,000	105,000,000
Net loss (gain) on investments and notes receivable	(250,000,000)	(333,000,000)	30,000,000
Contingent consideration net expense (benefit)	(136,000,000)	(100,000,000)	(35,000,000)
Inventory step-up amortization	34,000,000	58,000,000	46,000,000
Foreign exchange (gain) loss	27,000,000	32,000,000	358,000,000
Other, net	51,000,000	213,000,000	63,000,000
Increase (decrease) in operating assets and liabilities, excluding purchase accounting:
Trade accounts receivable	(279,000,000)	335,000,000	(130,000,000)
Inventories	(346,000,000)	(65,000,000)	(290,000,000)
Other assets	(134,000,000)	(265,000,000)	45,000,000
Accounts payable, accrued expenses and other liabilities	408,000,000	(28,000,000)	79,000,000
Cash provided by (used for) operating activities	1,870,000,000	1,508,000,000	1,836,000,000
Investing Activities
Purchases of property, plant and equipment and internal use software	(554,000,000)	(376,000,000)	(461,000,000)
Proceeds from sale of property, plant and equipment	14,000,000	12,000,000	7,000,000
Payments for acquisitions of businesses, net of cash acquired	(2,258,000,000)	(3,000,000)	(4,382,000,000)
Proceeds from divestiture of certain businesses	826,000,000	15,000,000	90,000,000
Proceeds from royalty rights	82,000,000	87,000,000	52,000,000
Proceeds from (payments for) settlements of hedge contracts	15,000,000	0	(199,000,000)
Proceeds from (payments for) investments and acquisitions of certain technologies	279,000,000	(146,000,000)	(149,000,000)
Cash provided by (used for) investing activities	(1,597,000,000)	(411,000,000)	(5,041,000,000)
Financing Activities
Payment of contingent consideration previously established in purchase accounting	(15,000,000)	(49,000,000)	(66,000,000)
Payments for royalty rights	(85,000,000)	(97,000,000)	(69,000,000)
Proceeds from royalty rights transfer	0	0	256,000,000
Payments on short-term borrowings	0	(2,950,000,000)	(1,000,000,000)
Proceeds from short-term borrowings, net of debt issuance costs	0	2,245,000,000	700,000,000
Net increase (decrease) in commercial paper	0	(714,000,000)	(575,000,000)
Payments on borrowings from credit facilities	0	(1,919,000,000)	0
Proceeds from borrowings on credit facilities	0	1,916,000,000	0
Payments on long-term borrowings and debt extinguishment costs	0	(1,260,000,000)	(3,560,000,000)
Proceeds from long-term borrowings, net of debt issuance costs	0	1,683,000,000	7,229,000,000
Cash dividends paid on preferred stock	(55,000,000)	(28,000,000)	0
Net proceeds from issuance of preferred stock in connection with public offering	0	975,000,000	0
Net proceeds from issuance of common stock in connection with public offering	0	975,000,000	0
Payments for repurchase of common stock	0	(535,000,000)	0
Cash used to net share settle employee equity awards	(50,000,000)	(59,000,000)	(65,000,000)
Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans	110,000,000	111,000,000	123,000,000
Cash provided by (used for) financing activities	(95,000,000)	293,000,000	2,973,000,000
Effect of foreign exchange rates on cash	(6,000,000)	(2,000,000)	10,000,000
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	173,000,000	1,388,000,000	(222,000,000)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	1,995,000,000	607,000,000	829,000,000
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	2,168,000,000	1,995,000,000	607,000,000
Supplemental Information
Income Taxes Paid	302,000,000	207,000,000	242,000,000
Interest Paid, Excluding Capitalized Interest, Operating Activities	338,000,000	359,000,000	449,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases	440,000,000	0	127,000,000
Non-cash impact of transferred royalty rights	$ (82,000,000)	$ (87,000,000)	$ 0